NEVROLOGIYADA FOTOBIOMODULYATSIYA VA UNI MIASTENIYA DAVOLASHDA QO‘LLASH ISTIQBOLLARi
;
Fotobiomodulyatsiya, miasteniya, past intensivlikdagi lazer terapiyasi, neyromushak uzatish, autoimmun kasalliklarAbstrak
Miasteniya bu skelet mushaklariga nerv impulslarining o‘tishi buzilishi bilan kechadigan surunkali autoimmun kasallikdir. Ushbu holat, odatda, jismoniy yuklamalar paytida kuchli mushak zaifligi va tez charchash bilan namoyon bo‘ladi. Imunosupressiv terapiya va simptomatik dorilarni o‘z ichiga olgan davo usullarining mavjudligiga qaramay, bemorlarni reabilitatsiya qilish samaradorligini oshiruvchi, dorisiz qo‘llaniladigan qo‘shimcha metodlarga ehtiyoj saqlanib qolmoqda. So‘nggi yillarda shunday istiqbolli yo‘nalishlardan biri sifatida fotobiomodulyatsiya (FBM) ilmiy va klinik doiralarda katta qiziqish uyg‘otmoqda. FBM — bu ma’lum to‘lqin uzunligidagi past intensivlikdagi lazer yoki LED (yorituvchi diod) nurlanishidan foydalanadigan fizioterapevtik usul bo‘lib, uning ta’siri mitoxondriya fermentlarini faollashtirish, hujayra ichidagi signal yo‘llarini modulyatsiya qilish, yallig‘lanish faolligini kamaytirish va mikroaylanishni yaxshilash orqali amalga oshadi
Iqtiboslar
Вейн А.М., Гусев Е.И. Неврология: Национальное руководство. — М.: ГЭОТАР-Медиа, 2022. — 816 с.
Бабаян А.А., Давидян С.А., Арутюнян И.Н. Возможности применения низкоинтенсивного лазерного излучения в клинической медицине // Вестник восстановительной медицины. — 2021. — №3. — С. 42–47.
Байтингер В.Ф., Лобанов А.А. Современные направления физиотерапии в неврологии // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2020. — Т. 120, №10. — С. 85–90.
Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation // AIMS Biophysics. — 2017. — Vol. 4, No. 3. — P. 337–361. https://doi.org/10.3934/biophy.2017.3.337
Karu T.I. Mitochondrial signaling in mammalian cells activated by red and near-IR radiation // Photochem Photobiol. — 2008. — Vol. 84. — P. 1091–1099. https://doi.org/10.1111/j.1751-1097.2008.00394.x
Huang Y.Y., Sharma S.K., Carroll J.D., Hamblin M.R. Biphasic dose response in low level light therapy // Dose-Response. — 2011. — Vol. 9, No. 4. — P. 602–618. https://doi.org/10.2203/dose-response.11-027.Hamblin
Salehpour F., Cassano P., Chang M., Hamblin M.R. Near-infrared photobiomodulation in neurodegenerative diseases: a systematic review // Aging Dis. — 2020. — Vol. 11, No. 2. — P. 302–321. https://doi.org/10.14336/AD.2019.0610
Naeser M.A., Saltmarche A., Krengel M.H., et al. Improved cognitive function after transcranial LED treatments in chronic traumatic brain injury // Photomed Laser Surg. — 2011. — Vol. 29, No. 5. — P. 351–358. https://doi.org/10.1089/pho.2010.2814
Almutairi A., Mahir A., Alqurashi M. et al. Efficacy of photobiomodulation for muscle performance and recovery: a systematic review and meta-analysis // Lasers Med Sci. — 2022. — Vol. 37. — P. 1287–1301. https://doi.org/10.1007/s10103-021-03312-4
Baybekov I., Mustafakulov Kh., Rasulov F. Laser therapy and plasmapheresis in myasthenia gravis: effects on erythrocytes and endothelium // Proc. SPIE. — 2010. — Vol. 7547. — P. 75470C. https://doi.org/10.1117/12.849960
Lan C.H., Hsu S.P., Cheng M.C. Application of Intravascular Laser Irradiation of Blood in a Patient with Refractory Myasthenia Gravis: A Case Report // World J Clin Cases. — 2022. — Vol. 10, No. 6. — P. 2023–2028. https://doi.org/10.12998/wjcc.v10.i6.2023
Zhou Y., Guo M., Wang J. et al. Extracellular vesicles carrying caspase-1 inhibitors alleviate symptoms of experimental autoimmune myasthenia gravis // J Control Release. — 2023. — Vol. 360. — P. 12–25. https://doi.org/10.1016/j.jconrel.2023.05.006
Alchinova I.B., Lysenko L.A., et al. Laser correlation spectroscopy in diagnostics of myasthenia gravis // J Biomed Opt. — 2014. — Vol. 19, No. 2. — P. 021103. https://doi.org/10.1117/1.JBO.19.2.021103
Stefaniotou M., Tranos P., Kotsolis A., et al. Central serous chorioretinopathy after corticosteroid therapy for myasthenia gravis: treatment with argon laser photocoagulation // Case Rep Ophthalmol. — 2013. — Vol. 4, No. 2. — P. 112–117. https://doi.org/10.1159/000351440
Huang H., Zhang L., et al. Low-level laser therapy in experimental autoimmune myasthenia gravis: mitochondrial modulation // Neural Regen Res. — 2016. — Vol. 11, No. 30. — P. 1898–1905. https://doi.org/10.4103/1673-5374.193237
Gupta A., Dai T., Hamblin M.R. Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion // Lasers Surg Med. — 2014. — Vol. 46. — P. 89–97. https://doi.org/10.1002/lsm.22191
Khan I., Arany P.R. Photobiomodulation therapy for tissue healing: pathophysiology and mechanisms // J Dent Res. — 2015. — Vol. 94, No. 9. — P. 1177–1186. https://doi.org/10.1177/0022034515593597
Chung H., Dai T., Sharma S.K., et al. The nuts and bolts of low-level laser (light) therapy // Ann Biomed Eng. — 2012. — Vol. 40, No. 2. — P. 516–533. https://doi.org/10.1007/s10439-011-0454-7
Lopes-Martins R.A., Marcos R.L., et al. Photobiomodulation and sports medicine: a new therapeutic approach for performance and recovery // Br J Sports Med. — 2018. — Vol. 52, No. 10. — P. 595–596. https://doi.org/10.1136/bjsports-2017-098272
Bicknell B., Liebert A., Kiat H. Neuroprotective mechanisms of photobiomodulation: evidence from pre-clinical and clinical studies // Mol Neurobiol. — 2021. — Vol. 58, No. 5. — P. 2237–2259. https://doi.org/10.1007/s12035-020-02267-4
